Repligen: 2Q Earnings Snapshot
WALTHAM, Mass. (AP) _ Repligen Corp. (RGEN) on Thursday reported second-quarter net income of $8.1 million.
On a per-share basis, the Waltham, Massachusetts-based company said it had net income of 17 cents. Earnings, adjusted for non-recurring costs, came to 31 cents per share.
The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 25 cents per share.
The drug developer posted revenue of $70.7 million in the period, which also beat Street forecasts. Five analysts surveyed by Zacks expected $64.2 million.
Repligen expects full-year earnings in the range of 94 cents to 98 cents per share, with revenue in the range of $264 million to $268 million.
Repligen shares have climbed 79% since the beginning of the year. The stock has risen 95% in the last 12 months.